Schonfeld Strategic Advisors LLC Veracyte, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 46,794 shares of VCYT stock, worth $1.53 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,794
Previous 89,244
47.57%
Holding current value
$1.53 Million
Previous $1.98 Million
48.71%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding VCYT
# of Institutions
257Shares Held
82.2MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$254 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$244 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$224 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.81MShares$222 Million1.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.46MShares$113 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.33B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...